Andrew S Day Selected Research

S100A12 Protein

1/2020	Fecal Markers of Inflammation and Disease Activity in Pediatric Crohn Disease: Results from the ImageKids Study.
12/2017	S100A12 in renal and cardiovascular diseases.
3/2017	Fecal biomarkers in inflammatory bowel disease.
12/2015	Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis.
10/2015	Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
4/2015	Intestinal inflammation and impact on growth in children with cystic fibrosis.
9/2014	Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.
2/2013	S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.
1/2012	Update of faecal markers of inflammation in children with cystic fibrosis.
12/2011	Respiratory disease and early serum S100A12 changes in very premature infants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew S Day Research Topics

Disease

55	Crohn Disease (Crohn's Disease) 11/2020 - 07/2006
41	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022 - 05/2006
28	Inflammation (Inflammations) 01/2022 - 05/2006
11	Ulcerative Colitis 12/2019 - 01/2008
8	Infections 01/2022 - 05/2002
6	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 05/2015
4	Vitamin D Deficiency 01/2019 - 03/2011
4	Pediatric Crohn's disease 01/2015 - 04/2010
3	Celiac Disease (Celiac Sprue) 01/2020 - 01/2019
3	Neoplasms (Cancer) 01/2020 - 05/2015
3	Fibrosis (Cirrhosis) 01/2017 - 06/2009
3	Hypersensitivity (Allergy) 01/2014 - 01/2008
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020 - 05/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2017
2	Disease Progression 01/2019 - 12/2015
2	Iron Deficiencies 01/2017 - 02/2015
2	Colitis 01/2017 - 01/2013
2	Liver Diseases (Liver Disease) 01/2017 - 06/2015
2	Dysbiosis 10/2016 - 01/2015
2	Pancreatitis 04/2015 - 11/2013
2	Intestinal Diseases (Diseases, Intestinal) 01/2014 - 01/2011
2	Eosinophilia 01/2014 - 07/2008
2	Anaphylaxis (Anaphylactic Shock) 09/2009 - 01/2008
2	Gastroesophageal Reflux (GERD) 09/2002 - 09/2002
1	Sepsis (Septicemia) 01/2022
1	Exocrine Pancreatic Insufficiency 01/2022
1	Intestinal Failure 01/2022
1	Chronic Disease (Chronic Diseases) 10/2021
1	COVID-19 03/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Mesenteric Ischemia 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Necrotizing Enterocolitis 01/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2019
1	Colonic Diseases 01/2018
1	Ascites 01/2017
1	Biliary Atresia 01/2017
1	Cellulitis 01/2017
1	Jaundice (Icterus) 01/2017
1	Body Weight (Weight, Body) 01/2017

Drug/Important Bio-Agent (IBA)

23	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 05/2006
19	Biomarkers (Surrogate Marker)IBA 12/2022 - 04/2010
13	S100A12 ProteinIBA 01/2020 - 07/2006
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2018 - 10/2006
4	Pharmaceutical PreparationsIBA 10/2021 - 04/2015
4	Vitamin D FDA LinkGeneric 01/2021 - 10/2015
4	2-mercaptopurineIBA 01/2021 - 09/2009
4	OsteoprotegerinIBA 01/2020 - 02/2011
4	LactoferrinIBA 12/2017 - 09/2014
4	S100 Proteins (S 100 Protein)IBA 03/2017 - 05/2006
4	C-Reactive ProteinIBA 05/2016 - 01/2010
3	Infliximab (Remicade)FDA Link 01/2020 - 09/2009
3	Glutens (Glutelin)IBA 01/2019 - 05/2005
3	Cholecalciferol (Vitamin D3)FDA Link 01/2019 - 10/2015
3	CytokinesIBA 01/2017 - 01/2008
2	Peroxidase (Myeloperoxidase)IBA 12/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2017
2	Capsules (Microcapsules)IBA 12/2017 - 09/2007
2	AlbuminsIBA 01/2017 - 04/2010
2	Interleukin-12 (IL 12)IBA 01/2017 - 01/2011
2	IronIBA 01/2017 - 02/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2016 - 05/2007
2	DefensinsIBA 10/2015 - 02/2009
2	Azathioprine (Imuran)FDA LinkGeneric 04/2015 - 11/2013
2	MucinsIBA 10/2014 - 01/2011
2	Indicators and Reagents (Reagents)IBA 02/2013 - 01/2008
2	DNA (Deoxyribonucleic Acid)IBA 12/2010 - 08/2008
2	Interleukin-18 (Interleukin 18)IBA 01/2008 - 11/2004
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022
1	taurolidineIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	IsoenzymesIBA 01/2020
1	Pyruvate KinaseIBA 01/2020
1	Fatty Acid-Binding ProteinsIBA 01/2020
1	Oncostatin MIBA 01/2020
1	AntioxidantsIBA 12/2019
1	CurcuminIBA 11/2019
1	Phenobarbital (Luminal)FDA Link 04/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	SugarsIBA 01/2018
1	Arginine (L-Arginine)FDA Link 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	InterleukinsIBA 01/2017
1	Ferritins (Ferritin)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 01/2017
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017
1	Monocyte Chemoattractant ProteinsIBA 01/2017

Therapy/Procedure

29	Therapeutics 01/2020 - 10/2006
29	Enteral Nutrition (Feeding, Tube) 11/2019 - 10/2006
4	Remission Induction 04/2013 - 02/2011
3	Gluten-Free Diet 03/2021 - 01/2019
2	Biological Therapy 01/2018 - 05/2010
2	Transplantation 01/2017 - 06/2015
1	Central Venous Catheters 01/2022
1	Catheters 01/2022
1	Parenteral Nutrition 01/2022
1	Liver Transplantation 01/2017
1	Hepatic Portoenterostomy 01/2017